Policy / Regulatory

Pudong New Area Aims to Boost Healthcare with Comprehensive Reform Plan

CompanyDrug

AstraZeneca Wins FDA Nod for Airsupra in Asthma Treatment

CompanyDrug

Gilead’s Trodelvy Misses Primary Endpoint in Late-Stage NSCLC Trial

Policy / Regulatory

NHC Unveils Updated Anti-Tumor Drug Guidelines for 2023 with New Drug Additions

CompanyDeals

Jiangsu Recbio Technology Strikes Licensing Deal with SPIMACO for 9-Valent HPV Vaccine

CompanyDeals

Suzhou Jade Biomedical Partners with Hopstem Biotechnology for Cell Therapy Advancements

CompanyDeals

Digital Precision Medicine Secures Over $28 Million in Series C Financing

CompanyDrug

NMPA Grants Marketing Approval for Hui Sheng Bio-pharmaceutical’s Janagliflozin

CompanyDrug

Novartis Lutathera Combo Therapy Shows Significant Progress in GEP-NETs

CompanyDrug

AstraZeneca’s Imfinzi Meets Primary Endpoint in Hepatocellular Carcinoma Trial

CompanyDrug

J&J’s Balversa Receives Full FDA Approval for Urothelial Carcinoma Treatment

Policy / Regulatory

Shandong Province Launches Initiatives to Accelerate Pharmaceutical Innovation and Growth